Objectives: Mechanically ventilated critically ill patients receive significant amounts of sedatives and analgesics that increase their risk of developing coma and delirium. We evaluated the impact of a "Wake-up and Breathe Protocol" at our local ICU on sedation and delirium.
F ive million Americans are admitted to ICUs annually due to life-threatening illnesses (1) , and approximately 36% of these critically ill patients receive mechanical ventilation during their ICU stay (2) , which is usually associated with significant amounts of sedative and analgesic use (3) . An optimal sedation strategy is highly desirable, as inadequate sedation can lead to patient-ventilator asynchrony, patient agitation, and unplanned extubations, while excessive sedation can result in an increased duration of mechanical ventilation, a higher length of ICU and hospital stay (4) , and can predispose the patient to delirium (5) .
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Dr. Khan received support for article research from the National Institutes of Health (NIH). His institution received grant support from the National Institute on Aging (NIA), the NIH-NIA MIND USA (R01 AG035117), and Indiana University Health (VFR-398 Khan). His work on the project was supported through a Career Development Award from the NIA (K23-AG043476 Sedation strategies in the ICU have seen a change over the last 2 decades with the publication of studies showing the efficacy of sedation vacation (6) , along with the pairing of sedation and ventilator weaning protocols (7) , in reducing duration of mechanical ventilation and ICU length of stay. Both randomized controlled trials showed a decrease in benzodiazepine use among intervention patients, suggesting that the favorable outcomes could be attributed to the reduction in sedation under well-controlled conditions. In March 2011, as a response to the evidence on the efficacy of the sedation vacation and spontaneous breathing practice, we localized and implemented the "Wake Up and Breathe Protocol" developed by Girard et al (7) to reduce variations in sedation levels across our ICU care teams, especially on the weekends.
Since 2009, the Indiana University Delirium study group has been actively conducting a randomized controlled trial: the Pharmacological Management of Delirium (PMD) (ClinicalTrials.gov identifier: NCT00842608) (8) in the same ICU. To identify eligible participants for the trial, ICU patients are regularly screened for level of sedation, coma, and delirium. The access to this large collection of screening data allowed us to assess the effect of our awakening and breathing protocol in decreasing sedation levels and acute brain dysfunction (coma/delirium) in a pre/post implementation study design. The primary hypothesis of our study was that implementation of a "Wake Up and Breathe Program" in a real-world setting will decrease sedation levels among critically ill mechanically ventilated patients. The secondary hypothesis was that such a program will also reduce the burden of coma and delirium in our ICU.
METHODS

Study Setting and Patient Population
The study was approved by the Institutional Review Board of the Indiana University Purdue University at Indianapolis. Patients admitted to the ICU services of Wishard Memorial Hospital (WMH) from June 1, 2010, to January 8, 2013, were included in the study. WMH is a 457-bed, university-affiliated, urban public hospital with an average of 1,200 ICU admissions/year. It has an eight-bed surgical ICU (SICU) and a 14-bed medical ICU (MICU) and coronary ICU. The MICU and SICU are staffed identically at a nurse-to-patient ratio of 1:2 and 1:1 when necessary. There were no changes in the patients' characteristics or staffing practices of these ICUs during the study period.
Patients are screened for the PMD study if they are 1) admitted to the WMH ICUs; 2) 18 years old or older; and 3) able to speak English. Patients are excluded if they are 1) not English speaking; 2) hearing impaired; 3) legally blind; 4) admitted with alcohol intoxication; 5) prisoners; or 6) diagnosed as having an Axis 1 Psychiatric disorder. Consecutively admitted mechanically ventilated patients with the above screening criteria are included for the evaluation of the Wake Up and Breathe Program.
Procedures and Data Collection
Outcome Measures. The Richmond Agitation Sedation Scale (RASS) (9) was used to assess the level of sedation. RASS is a valid and reliable sedation assessment scale with items ranging from -5 to +4, with negative items denoting deeper levels of sedation. A RASS score of -4 or -5 is indicative of coma; -3 and -2 depict moderate and light sedation, respectively; -1 depicts drowsiness; 0 depicts alert and calm state; and the positive items from +1 to +4 indicate various degrees of restlessness and agitation. Confusion Assessment Method for the ICU (CAM-ICU) was used to screen for delirium for patients with a RASS score greater than or equal to -3 (10) . Patients were identified as delirious if their RASS score was -3 (responsive to verbal stimuli) or greater and had a positive CAM-ICU result. Incident delirium was defined as a positive CAM-ICU after an initial negative result. Prevalent delirium was defined as any CAM-ICU positive result during the ICU stay. Patients who were either delirious or comatose at any time point were classified as having acute brain dysfunction. The RASS and CAM-ICU data were collected by trained research personnel who conducted two sedation/delirium assessments each day, once in am and once in pm. Patients were assessed within 24 hours of ICU admission and then daily until they become delirious, died, or were discharged. Wake Up and Breathe Protocol. Our protocol (Appendix 1, Supplemental Digital Content 1, http://links.lww.com/CCM/ B84) was adapted from the Awakening and Breathing Controlled (ABC) trial (7) . Prior to the protocol implementation, the sedation practices involve continuous analgesics and sedatives infusions based on physicians' discretion. The protocol mandated patients' sedatives to be discontinued at 7 am after they pass the safety screen. Once awake, a spontaneous breathing trial is initiated. If patients tolerate the breathing trial for 1 hour, attending physicians are notified. In cases of intolerance of sedation interruption or spontaneous breathing, sedatives are restarted at half of the previous dose and patients are returned to assisted ventilation. Multidisciplinary weekly group sessions over a period of 3 months were organized to develop the protocol and to train the ICU personnel.
Baseline demographics, such as age, sex, race, patients' severity of illness, principal diagnoses, duration of mechanical ventilation, and length of hospital stay, were also recorded.
Statistical Analysis
Descriptive data are expressed as counts (%) for categorical variables, medians (interquartile range [IQR]) for skewed variables, and means (sd) for symmetric variables. We used chisquare tests to compare incident and prevalent delirium, coma, acute brain dysfunction, and hospital mortality rates between the pre/post protocol cohorts. Logistic regression was used to adjust for potential confounders such as age, race, gender, severity of illness, principal diagnosis, and ICU as described in Table 1 . Linear mixed models, with appropriate contrasts, were used to assess changes in daily RASS scores. Poisson regression was used to assess differences in number of days on mechanical ventilation between the pre/post protocol cohorts while adjusting for potential confounders. The Wilcoxon rank-sum test was used to compare hospital length of stay between the www.ccmjournal.org e793 pre and post cohorts. Statistical significance was defined as p value of less than 0.05. All analyses were performed using SAS version 9.3 (SAS Institute, Cary, NC).
RESULTS
Three thousand nine hundred two RASS assessments were performed on 702 unique ICU (262 preimplementation and 440 postimplementation) admissions from June 1, 2010, to January 8, 2013. Among these unique admissions, 443 (141 preimplementation and 302 postimplementation) had at least one CAM-ICU assessment and were used as the cohort for estimating prevalence of delirium. Of those assessed, 229 (61 preimplementation and 168 postimplementation) were negative for delirium at the first CAM-ICU assessment and were used as the cohort for estimating incidence of delirium. The Wake Up and Breathe Protocol was initiated on March 1, 2011. Patients admitted during the 9 months prior to protocol implementation (n = 262) were selected as control, whereas those admitted during the 22 months after implementation (n = 440) were selected as the intervention cohort. Table 1 describes the patients' characteristics of the study cohorts. The median RASS score was -4 (IQR, -5 to -3) for the overall study population on weekdays and -4 (IQR, -5 to -4) on weekends (mean RASS, -3.6 [sd = 1.65] on weekdays and -3.9 [sd = 1.36] on weekends). The incidence of delirium was 20.5% (47 of 229), and the prevalence was 58.9% (261 of 443) for the overall study period. The prevalence of coma was 75.2% (528 of 702) and that of acute brain dysfunction (coma/delirium) was 87.2% (612 of 702). Prior to the protocol implementation, patients had a median RASS of -4 (mean, -3.74) on weekdays and -5 (mean, -4.4) on weekends (adjusted mean difference, -0.44 [p < 0.0001]). After implementation of the protocol, there was an increase in the mean RASS on weekdays of 0.88 (p < 0.0001) and on weekends of 1.20 (p < 0.0001). Both SICU and MICU showed similar trends. Figure 1 shows the mean daily RASS score for mechanically ventilated patients in the MICU and SICU pre/ post implementation of the protocol.
The incidence of delirium in the preprotocol period was 23.0% (14 of 61) and the prevalence was 66.7% (94 of 141). Post protocol, the incidence and prevalence of delirium were 19.6% (33 of 168) and 55.3% (167 of 302), respectively. Although incidence did not change significantly, prevalence changed significantly from pre-to post-protocol implementation periods (incidence, p = 0.58; prevalence, p = 0.02). Coma prevalence did not decrease significantly (preprotocol, 78.2% [205 of 262]; postprotocol, 73.4% [323 of 440]; p = 0.15). When both delirium and coma were considered together as acute brain dysfunction, the prevalence decreased from 90.8% (238 of 262) in the preprotocol period to 85% (374 of 440) in the postprotocol phase (p = 0.02; unadjusted odds ratio = 0.571). After adjusting for age, race, gender, severity of illness, primary diagnosis, and ICU, the odds ratios postprotocol relative to preprotocol were incident delirium (0.718; 95% CI, 0.326-1.578; p = 0.40); prevalent delirium (0.650; 95% CI, 0.413-1.022; p = 0.06); coma (0.659; 95% CI, 0.446-0.974; p = 0.04); and acute brain dysfunction (0.505; 95% CI, 0.299-0.853; p = 0.01). The number of days on mechanical ventilation postprotocol was higher compared with preprotocol (median preprotocol, 4 d; postprotocol, 5 d; mean preprotocol, 6.1 d; postprotocol, 7.1 d; adjusted p ≤ 0.01). There were no differences in hospital length of stay (median preprotocol, 14 d; postprotocol, 14 d; p = 0.56) and in-hospital mortality (preprotocol, 19.5%; postprotocol, 19.6%; p = 0.97).
DISCUSSION
Implementation of a "Wake Up and Breathe Program" at our local hospital resulted in an improvement in overall RASS scores, the primary target that the implementation team wanted to achieve. The program was not able to reduce incidence or ICU-acquired delirium, but showed a trend toward reducing prevalent delirium among mechanically ventilated critically ill patients. Even though coma prevalence decreased after implementation of the protocol, the duration of mechanical ventilation was increased. These results demonstrate that implementing a sedation vacation and spontaneous breathing program as pioneered by Girard et al (7) may be feasible in a real-world setting, but may not be able to provide similar results as seen in the original trial. The effect sizes of interventions found in tightly controlled research environments could be substantially attenuated when implemented in a complex clinical setting.
Critical illness subjects patients to extreme stressors both directly through physiological derangements and indirectly through life-sustaining interventions such as mechanical ventilation. To reduce the anxiety and pain associated with critical illness, sedation and analgesia are frequently employed in mechanically ventilated patients for patient comfort, ease of care, and safety (3) . A liberal sedation strategy results in an overuse of these agents with an increase in oversedation, acute www.ccmjournal.org e795 brain dysfunction, and ICU and hospital length of stay (4-7). Instituting a "sedation vacation" strategy in the ICUs may be beneficial in countering the adverse effects associated with indiscriminate sedative usage (6, 7) . Similar strategy employed at our institution showed an improvement in the overall RASS scores. As we did not have drug dispensing data, we cannot attribute the RASS improvement to a decrease in sedative exposure, but based on prior literature (6, 7) , this seems to be the most plausible explanation. The RASS scores, though improved after the Quality Improvement (QI) project, still remained in the deeply sedated range. This is a cause for concern as there are data reflecting the impact of deeper sedation on patient outcomes (11) . This prompted the implementation team to start a checklist project to impress upon the ICU multidisciplinary team the importance of adhering to national sedation guidelines. In order to achieve the desired RASS targets, more frequent monitoring of RASS levels (every 4 hr) by the nursing personnel has been introduced in the local ICU. Our project was not able to decrease the hospital length of stay as seen in the original ABC trial (7) and on the contrary increased the duration of mechanical ventilation. The reasons behind the increased mechanical ventilation duration are unclear and could reflect conservative practice pattern at our institute. Instead of our daily awakening approach, using a protocolized analgesia, sedation, and delirium approach may have produced different results as shown in the studies by Skrobik et al (12) and Mehta et al (13) . The other potential explanations include the differences between a real-life implementation as compared to a rigorous clinical trial and differences in patient populations. No hospital mortality benefit was observed which was consistent with the ABC trial results (7) .
Our QI project has several limitations. 1) Due to the pre/ postdesign, we could not definitively attribute the improvement in the sedation scores and acute brain dysfunction to our implementation project. An inherent risk in conducting timedependent studies is that the changes observed are a function of time and are not related to the intervention. Analysis of our data did not show a simple linear time trend, making it more likely that our positive findings were attributable to our intervention. 2) We did not have the drug dispensing data, necessary to show that the protocol actually reduced the drug exposure. 3) Our study was conducted at a single site, so the results may not be generalizable. 4) We did not collect data on failed spontaneous awakening and spontaneous breathing attempts; therefore, adherence to the intervention could not be reported.
The strengths of the project include the following: 1) We were able to implement a research protocol in a real-world setting, thus demonstrating the feasibility. 2) We had a robust data collection by using an ongoing clinical study. 3) RASS and CAM-ICU were administered twice daily. 4) We enrolled a diverse patient population including females and African American patients.
